{"transactions":[{"id":734329,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-17T23:08:24.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":12555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":12555,"derivative":{"exercise_price":0.7293,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":12555},"source":{"system":"sec-edgar","filing":"0001104659-26-075284","document":"tm2618211-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000110465926075284/tm2618211-7_4seq1.xml","form_type":"4"}},{"id":734328,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T23:08:24.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4180,"source":{"system":"sec-edgar","filing":"0001104659-26-075284","document":"tm2618211-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000110465926075284/tm2618211-7_4seq1.xml","form_type":"4"}},{"id":766187,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T20:05:21.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 20, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":67000,"derivative":{"exercise_price":0.9946,"expiration_date":"2036-05-20","underlying":"Voting Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001193125-26-236848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000119312526236848/ownership.xml","form_type":"4"}},{"id":1095477,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:26:46.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 30, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":67000,"derivative":{"exercise_price":1.45,"expiration_date":"2035-06-30","underlying":"Voting Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0000950170-25-093020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000095017025093020/ownership.xml","form_type":"4"}},{"id":1118107,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-09T20:04:28.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4185,"derivative":{"exercise_price":1.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001104659-25-057813","document":"tm2517366-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000110465925057813/tm2517366-4_4seq1.xml","form_type":"4"}},{"id":1118106,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:04:28.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":1045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":1045,"source":{"system":"sec-edgar","filing":"0001104659-25-057813","document":"tm2517366-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000110465925057813/tm2517366-4_4seq1.xml","form_type":"4"}},{"id":1397972,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-30T21:37:40.000Z","date":"2024-09-27","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of September 27, 2024."}],"balance_after":1000,"derivative":{"exercise_price":1.41,"expiration_date":"2034-09-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-110461","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000095017024110461/ownership.xml","form_type":"4"}},{"id":1479289,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:20:04.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":47500,"derivative":{"exercise_price":8.88,"expiration_date":"2034-06-11","underlying":"Voting Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000950170-24-073693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000095017024073693/ownership.xml","form_type":"4"}},{"id":1753232,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-31T22:45:22.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of October 27, 2023."}],"balance_after":1000,"derivative":{"exercise_price":6.06,"expiration_date":"2033-10-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001171843-23-006565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000117184323006565/ownership.xml","form_type":"4"}},{"id":1792055,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-31T22:22:16.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option shall vest on August 31, 2024 and the remaining 75% shall vest in thirty-six (36) equal monthly installments, subject to the reporting person's continued service through the applicable vesting dates."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023."}],"balance_after":11666,"derivative":{"exercise_price":8.51,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0000950170-23-045862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000095017023045862/ownership.xml","form_type":"4"}},{"id":1854614,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T22:14:27.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":35000,"derivative":{"exercise_price":2.66,"expiration_date":"2033-06-12","underlying":"Voting Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-23-015640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000089924323015640/doc4.xml","form_type":"4"}},{"id":1901099,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-08T21:17:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall vest in full on May 5, 2024, subject to the reporting person's continued service through and including the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":3.8999,"expiration_date":"2033-05-05","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-23-057260","document":"tm2314936-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000110465923057260/tm2314936-2_4seq1.xml","form_type":"4"}},{"id":2242611,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T11:30:29.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2023."}],"balance_after":15000,"derivative":{"exercise_price":0.9728,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-021142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000089924322021142/doc4.xml","form_type":"4"}},{"id":2245151,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:30:34.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":9146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 1, 2023 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":9146,"derivative":{"exercise_price":3.17,"expiration_date":"2032-05-31","underlying":"Voting Common Stock","underlying_shares":9146},"source":{"system":"sec-edgar","filing":"0000899243-22-020965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000089924322020965/doc4.xml","form_type":"4"}},{"id":2361304,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-02T13:30:15.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the total number of shares subject to the option shall vest on March 1, 2023 and the remaining 50% shall vest on March 1, 2024, subject to the reporting person's continuous service with Molecular Templates, Inc."}],"balance_after":25000,"derivative":{"exercise_price":2.35,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-008515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000089924322008515/doc4.xml","form_type":"4"}},{"id":2632241,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-16T20:34:11.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":9146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in 12 equal monthly installments upon the completion of each month of continuous service to the Issuer after May 4, 2022."}],"balance_after":9146,"derivative":{"exercise_price":15,"expiration_date":"2031-07-14","underlying":"Voting Common Stock","underlying_shares":9146},"source":{"system":"sec-edgar","filing":"0000899243-21-028648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000089924321028648/doc4.xml","form_type":"4"}},{"id":2632240,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":37306,"kind":"person","name":"Gruia Gabriela","position":1,"cik":"0001860326","reported_name":"Gruia Gabriela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-16T20:34:11.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":9146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in 36 equal monthly installments upon the completion of each month of continuous service to the Issuer after May 4, 2021 ."}],"balance_after":9146,"derivative":{"exercise_price":15,"expiration_date":"2031-07-14","underlying":"Voting Common Stock","underlying_shares":9146},"source":{"system":"sec-edgar","filing":"0000899243-21-028648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860326/000089924321028648/doc4.xml","form_type":"4"}}]}